Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 3/20 | 0.64 |
| ▸ | FGFR1 | P11362 | 13/20 | 0.47 |
| ▸ | FGFR2 | P21802 | 13/20 | 0.47 |
| ▸ | FGFR3 | P22607 | 13/20 | 0.47 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.43 |
| ▸ | ATR | Q13535 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4044231 | 0.91 | EGFR (0.78) | EGFRFGFR1FGFR2FGFR3MET | |
| SCHEMBL4042032 | 0.87 | EGFR (0.62) | EGFRFGFR1FGFR2FGFR3MET | |
| SCHEMBL4044782 | 0.86 | EGFR (0.61) | EGFRFGFR1FGFR2FGFR3MET | |
| SCHEMBL4045787 | 0.84 | EGFR (0.78) | EGFRFGFR1FGFR2FGFR3MET | |
| SCHEMBL4045589 | 0.83 | EGFR (0.56) | EGFRFGFR1FGFR2FGFR3MET | |
| SCHEMBL4047605 | 0.82 | EGFR (0.62) | EGFRFGFR1FGFR2FGFR3MET | |
| SCHEMBL4041919 | 0.81 | EGFR (0.79) | EGFRFGFR1FGFR2FGFR3ATR | |
| SCHEMBL4045492 | 0.81 | EGFR (0.78) | EGFRFGFR1FGFR2FGFR3MET | |
| SCHEMBL4043377 | 0.81 | EGFR (0.78) | EGFRFGFR1FGFR2FGFR3NTRK1 | |
| SCHEMBL4045605 | 0.80 | EGFR (0.74) | EGFRFGFR1FGFR2FGFR3MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009024825-A1 | 2-PYRAZINYLBENZIMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2009-02-26 | — | — | WO | disclosed |